Indexed in Journament
OncoTargets and therapy
ISSN 1178-6930· EN
Login or register to claim ownership or editorship of this journal.
34.0
050100
The Journament Score is computed from platform statistics — reader engagement,
accessibility, publication timeliness, keyword breadth, community impact and content
distribution — into a single 0–100 figure, recalculated as new articles and metadata
are indexed. Dimensions that cannot be measured for this journal are excluded rather
than estimated. It is independent of the paid AI Quality Analysis, which never
affects this score or the ranking.
Full methodology →
About This Journal
| Short Name | Onco Targets Ther |
|---|---|
| Abbreviated Name | oncotargets and therapy |
| ISSN | 1178-6930 |
| URL | http://www.dovepress.com/oncotargets-and-therapy-journal |
Quality Profile
7 of 12 dimensions measured
This journal
Average of scored journals
Platform statistics — the free Journament Score
AI Quality Analysis — separate paid product, ranks nothing
5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.
Show the numbers
| Dimension | This journal | Corpus average |
|---|---|---|
| Engagement | 31.2 | 30.4 |
| Accessibility | 20.0 | 23.1 |
| Timeliness | 0.0 | 3.0 |
| Diversity | 27.8 | 25.8 |
| Innovation | 70.0 | 24.1 |
| Community Impact | 7.9 | 4.2 |
| Content Distribution | 74.6 | 89.2 |
| Content Quality | — | 55.1 |
| Ethics & Transparency | — | 40.5 |
| Editorial Standards | — | 33.0 |
| Publication Regularity | — | 52.9 |
| Geographic Reach | — | 30.4 |
Publications Per Year
Articles (24)
2015
Vol. 8
, pp. 157--168
527 views
DOI
Abstract
2015
Vol. 8
, pp. 1533--1541
510 views
DOI
Abstract
2015
Vol. 8
, pp. 1533-1541
490 views
DOI
Abstract
2019
Vol. 12
, pp. 5449-5455
450 views
DOI
Abstract
2019
Vol. Volume 12
, pp. 4281-4285
449 views
Abstract
2015
Vol. 8
, pp. 157-168
438 views
DOI
Abstract
2020
Vol. 13
, pp. 309-321
423 views
DOI
Abstract
2019
Vol. 12
, pp. 5989-6000
395 views
DOI
Abstract
2017
Vol. 2
, No. 2
, pp. 237-244
385 views
DOI
Abstract
2020
FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway.
Vol. 13
, pp. 451-463
377 views
DOI
Abstract
2020
Vol. 13
, pp. 4465-4471
179 views
DOI
Abstract
2020
Vol. Volume 13
, pp. 4465-4471
93 views
Abstract
2020
FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway.
Vol. 13
, pp. 451-463
377 views
DOI
Abstract
2020
Vol. 13
, pp. 309-321
423 views
DOI
Abstract
2019
Vol. Volume 12
, pp. 4741-4753
347 views
Abstract
2019
Vol. 12
, pp. 11691-11700
287 views
DOI
Abstract
2019
Vol. Volume 12
, pp. 4281-4285
449 views
Abstract
2019
Vol. 12
, pp. 5449-5455
450 views
DOI
Abstract
2019
Vol. 12
, pp. 5311-5322
253 views
DOI
Abstract
2019
Vol. 12
, pp. 5989-6000
395 views
DOI
Abstract